Robert Karr
Director Ejecutivo en Drosmed LLC .
Perfil
Robert W.
Karr is the founder of Euclises Pharmaceuticals, Inc. (2011).
He is currently the President & Chief Executive Officer of Drosmed LLC and the Managing Member of Startup Partners International LLC.
Dr. Karr's former positions include Chief Executive Officer of Zevra Therapeutics, Inc., President, Chief Executive Officer & Director of Arch Oncology, Inc. (2015-2016), and Independent Director of Idera Pharmaceuticals, Inc. (2005-2015).
He also worked as a Senior Executive-Global Research & Development at Pfizer Inc. (2000-2004) and as Vice President-Research & Development Strategy at Warner-Lambert Co. Dr. Karr's education includes an undergraduate degree from Southwestern University (1971) and a doctorate from the University of Texas Medical Branch (1975).
Dr. Karr is also the founder of Indalo Therapeutics, Inc.
Cargos activos de Robert Karr
Empresas | Cargo | Inicio |
---|---|---|
Drosmed LLC
Drosmed LLC Drugstore ChainsRetail Trade Drosmed LLC provides and develops drugs. It utilizes the fruit fly drosophila to take a whole animal approach to drug discovery for cancer metastasis and for diabetes-related diseases. The company was founded by Thomas John Baranski and Ross L. Cagan in 2006 and is headquartered in St. Louis, MO. | Director Ejecutivo | - |
Startup Partners International LLC | Corporate Officer/Principal | 01/01/2010 |
Antiguos cargos conocidos de Robert Karr.
Empresas | Cargo | Fin |
---|---|---|
VERSEON CORP | Director/Miembro de la Junta | 05/11/2018 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Director/Miembro de la Junta | 08/06/2015 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Director/Miembro de la Junta | 05/05/2011 |
Startup Midwest Management LLC | Corporate Officer/Principal | 01/02/2010 |
PFIZER, INC. | Director Técnico/Científico/I+D | 01/12/2004 |
Formación de Robert Karr.
Southwestern University | Undergraduate Degree |
University of Texas Medical Branch | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
PFIZER, INC. | Health Technology |
ZEVRA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 15 |
---|---|
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Verseon Corp.
Verseon Corp. Miscellaneous Commercial ServicesCommercial Services Verseon Corp. engages in the business of developing and designing pharmaceutical products. The firm also focuses on drug discovery technology to seed growing portfolio of programs targeting diverse disease areas which includes anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. The company was founded by Eniko Fodor, David Kita, and Adityo Prakash in 2002 and is headquartered in Fremont, CA. | Commercial Services |
Euclises Pharmaceuticals, Inc.
Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Health Services |
Tansna Therapeutics, Inc.
Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Tansna Therapeutics, Inc. develops and offers oral drugs to treat epilepsy. It focuses on novel therapies for the treatment of central nervous system disorders. The company was founded by Max Baker in 2010 and is headquartered in St. Louis, MO. | Distribution Services |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Idera, Inc.
Idera, Inc. Packaged SoftwareTechnology Services IDERA, Inc. operates as a B2B (business to business) software company. its products include DESIGN Models and Databases; MONITOR Database Performance; PROTECT Database Integrity; and MANAGE IT Performance. The company was founded by Richard Jan Pleczko, Michael J. Clark, and Roderick Endo in 2000 and is headquartered in Houston, TX. | Technology Services |
Startup Midwest Management LLC | |
Karr Pharma Consulting LLC | |
Drosmed LLC
Drosmed LLC Drugstore ChainsRetail Trade Drosmed LLC provides and develops drugs. It utilizes the fruit fly drosophila to take a whole animal approach to drug discovery for cancer metastasis and for diabetes-related diseases. The company was founded by Thomas John Baranski and Ross L. Cagan in 2006 and is headquartered in St. Louis, MO. | Retail Trade |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
Startup Partners International LLC | |
Antegrin Therapeutics LLC
Antegrin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Antegrin Therapeutics LLC develops novel therapies for fibrotic diseases. It focuses on idiopathic pulmonary fibrotic diseases, which are conditions that involve out-of-control scarring of organs. The company was founded by David Griggs and Peter Ruminski in 2012 and is headquartered in St. Louis, MO. | Health Technology |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Robert Karr